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lent prognosis.  Conclusions: The angioinvasive variant of 
PCALCL is rare but distinctive and prone to misinterpretation 
as aggressive lymphoma due to its histological features. 
 © 2013 S. Karger AG, Basel 
 Introduction 
 The spectrum of primary cutaneous CD30+ lympho-
proliferative disorders (CD30+ LPD) comprises anaplas-
tic large cell lymphoma (ALCL) and lymphomatoid pap-
ulosis (LyP)  [1–9] . Five LyP types (A, B, C, D, E) have 
been identified in recent years, with some differences in 
the histopathological (and also clinical) appearances  [10–
13] . Irrespective of its histopathological pattern, LyP is 
clinically characterized by a variable number of self-heal-
ing papulonodular lesions, with the typical waxing and 
waning course, whereby individual lesions undergo spon-
taneous regression within a few weeks, sometimes ac-
companied by ulceration on top of the lesions and occa-
sionally leaving behind varioliform scars  [14–16] .
 LyP type E, also known as angioinvasive LyP, typically 
shows fewer lesions in comparison to other LyP types and 
characteristically manifests as eschar-like ulcers that often 
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 Abstract 
 Background: Primary cutaneous anaplastic large cell lym-
phoma (PCALCL) presents with solitary or grouped exophyt-
ic tumors and cohesive infiltrates of large CD30+ T cells.  Ob-
jective: To report an angioinvasive variant of PCALCL.  Meth-
ods: Retrospective analysis of clinicopathological features 
of this variant.  Results: The group consisted of six patients 
(median age 46 years) with a solitary flat necrotic lesion pref-
erentially located on the upper extremity. Histologically, 
there were angiocentric and angiodestructive infiltrates of 
medium-sized to large pleomorphic and anaplastic cells co-
expressing CD30 and CD8. Five patients were treated with 
surgical excision and one patient with radiotherapy. A re-
lapse was observed in one patient with spontaneous regres-
sion of the lesions suggesting a link to the recently described 
angioinvasive lymphomatoid papulosis (type E). All patients 
were alive without evidence of disease after a median fol-
low-up of 31 months (range 15–96), indicating an excel-
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exceed the size of the pre-existing papules or nodules  [12] . 
Angiocentric and angiodestructive infiltrates of CD30+ 
and mostly CD8+ lymphoid cells accompanied by necrotic 
areas are the typical histopathological features of this LyP 
variant. While working on the series of angioinvasive LyP, 
we observed 5 patients who displayed very similar if not 
identical morphological features, but presented with a soli-
tary large cutaneous lesion without spontaneous regression 
of the lesion  [12] . Thus these cases were classified as pri-
mary cutaneous ALCL (PCALCL) and were therefore ex-
cluded from the series of LyP. Available follow-up demon-
strated that in all but one case the lesion remained solitary 
and there were no recurrences at other sites, in contrast to 
what was observed in patients with LyP type E. The goal of 
this paper is to present this rare variant of PCALCL with 
marked angiocentric and angiodestructive features and a 
CD30+CD8+ phenotype and to further demonstrate that 
LyP and PCALCL form a clinicopathological spectrum.
 Subjects and Methods 
 The subjects of this report are 6 patients with a similar clinico-
pathological presentation, including occurrence of a large solitary 
cutaneous lesion as well as angiocentric and angiodestructive infil-
trate of large atypical cells co-expressing CD30 and CD8. Of these, 
there were 2 newly identified patients and 4 of the 5 individuals who 
were originally excluded from the series of angioinvasive LyP  [12] .
 Light Microscopy 
 Tissues were fixed in 10% buffered formalin and embedded in 
paraffin. Hematoxylin and eosin-stained sections with a thickness 
of 4 μm were prepared. The following features were assessed: ul-
ceration of the epidermis, epidermal hyperplasia, vacuolar altera-
tion in the basal layer, prominent edema in the papillary dermis, 
perivascular or diffuse pattern of the infiltrates, infiltration and 
destruction of vessel walls, intraluminal thrombi, size (small, me-
dium, large) and morphology (pleomorphic, anaplastic) of lym-
phoid cells, presence of eosinophils and neutrophils, extravasated 
erythrocytes, extension of the infiltrate into the subcutis, perineu-
ral or intraneural invasion and adnexal involvement.
 Immunohistochemical Studies 
 Immunohistochemical studies were performed on formalin-
fixed paraffin-embedded tissue using the following antibodies: 
CD2 (1: 50; Novocastra/Leica-Microsystems, Heerbrugg, Switzer-
land), CD3 (1: 75; Dako, Glostrup, Denmark), CD4 (1: 2; Novocas-
tra/Leica-Microsystems), CD5 (1: 2; 4C7; Dako), CD7 (1: 25; Dako), 
CD8 (1: 400; Dako), CD20 (1: 600; Dako), CD30 (1: 75; Novocastra/
Leica-Microsystems), CD56 (RTU; Novocastra/Leica-Microsys-
tems), TIA (1: 50; Immunotech, Marseille, France), T cell receptor 
(TCR)-βF1 (8A3; 1: 50; Thermo Scientific, Fremont, Calif., USA), 
TCR-γ/δ (y3.20; 1: 100; Thermo Scientific) and CD246 (1: 50; ALK-
1; Dako). Appropriate positive controls were included. The num-
ber of antibodies used varied among individual cases depending 
on the available tissue. The results were assigned to one of the fol-
lowing four categories: immunoreaction in all of the affected ves-
sels and in a majority of the interstitial (extramural) infiltrate (+); 
immunoreaction in a majority of the affected vessels and in a ma-
jority of the interstitial infiltrate (+/–); immunoreaction in a mi-
nority of the affected vessels and in a minority of the interstitial 
infiltrate (–/+); no immunoreaction in any of the affected vessels 
or in the interstitial infiltrate (–).
 Molecular Biology 
 Five cases were studied for rearrangement of TCR-γ genes as 
described elsewhere  [17] . In brief, the TCR clonality studies were 
performed using three multiplex polymerase chain reactions with 
different primers from the variable region in each reaction (reac-
tion 1: Vg1 to 8; reaction 2: Vg9; reaction 3: Vg10, 11 and 12) and 
the same Cy-5-labeled primers from the conserved region (JGP1/2, 
JG1/2 and JGP). Additionally, in situ hybridization for EBV-en-
coded small RNA was performed (RTU; Novocastra/Leica-Micro-
systems) in 4 cases.
 Results 
 Clinical Presentation 
 There were 4 female and 2 male patients, with age at 
diagnosis ranging from 27 to 70 years (mean 47, median 
46). The lesions preferentially involved the upper extrem-
ity (4 cases, 67%), while the head and neck area and low-
er limbs were affected in the remaining 2 cases ( table 1 ). 
At initial presentation, the lesions were solitary tumors 
ranging in size from 1 to 5 cm in largest diameter with 
ulceration mentioned clinically in half of the cases 
( fig. 1 a). The lesions exceeded 2 cm in all but one case – 
the case with a 1-cm crusted lesion (case 6) which due to 
short history likely represented incipient disease ( fig. 1 b). 
After diagnosis, 5 patients underwent staging investiga-
tions to exclude extracutaneous disease, with negative re-
sults (in 1 patient pleomorphic adenoma of the parotid 
gland was found on work-up). Five patients were treated 
with excision only, whereas in the remaining case radio-
therapy was administered. Follow-up ranged from 15 to 
96 months (mean 39.5, median 31 months). None of the 
patients had any evidence of disease at the last check-up. 
Only 1 patient (case 5) experienced a relapse of disease 
with several grouped nodules occurring at the site of the 
original tumor 1 year after surgery. The lesions spontane-
ously regressed, but 2 years later several nodules devel-
oped, again regressing spontaneously.
 Histopathological Features 
 In all cases, there was an angiocentric/angiodestruc-
tive infiltrate in the dermis with destruction of several 
small to medium-sized vessels that often showed fibrin 
deposits in their walls, intraluminal thrombi and perivas-
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cular debris (fig. 2). Around intact or partly destructed 
vessels, the neoplastic cells often formed dense cuffs, in-
filtrating the vessels wall. The cells were pleomorphic or 
anaplastic, medium-sized to large, some with conspicu-
ous nucleoli. The infiltrate was either diffuse or perivas-
cular, but the in latter case the ‘perivascular’ pattern rath-
er resulted from conspicuous perivascular lymphoid cuffs 
in viable areas alternating with areas of dermal necrosis. 
Extension of the infiltrate into the subcutis was seen in 
half of the cases. Apart from atypical lymphocytes, nu-
merous eosinophils and extravasated erythrocytes were a 
feature in a majority of cases ( table 2 ).
Table 1.  Angioinvasive PCALCL: clinical features and follow-up of the patients
Case Sex Age Clinical presentation Staging/treatment Follow-up
1 F 50 solitary ulcerated tumor on the forearm developing 
during 3 weeks from, reportedly, closely grouped, 
confluent pustules and papules; leishmaniasis? 
sporotrichosis?
not available/
radiotherapy
NED, 20 months
2 F 46 solitary tumor on the lower leg negative/
excision
NED, 16 months
3 F 46 solitary tumor on the neck; keratoacanthoma? negative/
excision
NED, 96 months
4 F 70 3.5-cm ulcerated tumor on the dorsal hand negative/
excision
NED, 42 months
5 M 27 rapidly growing (over 2 weeks) solitary 5 × 4-cm 
tumor with central necrosis on the arm
negative/
excision
local relapse as several nodules 1 year 
later, with spontaneous regression; 
second identical relapse 2 years later, 
then NED at 48 months
6 M 42 recent solitary 1-cm plaque on the occipital area negative/
excision
NED, 15 months
 Case 1: history of laryngeal carcinoma. Case 4: pleomorphic adenoma of the right parotid gland found on staging investigations.
NED = No evidence of disease.
a b
 Fig. 1. Clinical presentation of angiocentric ALCL: solitary ulcerated lesions covered by black eschar-like crust. 
A 5 × 4 cm tumor in case 5 ( a ) and a 1-cm scalp lesion in case 6 ( b ). 
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 Immunohistochemical Findings 
 In all cases the neoplastic cells co-expressed CD30 and 
CD8. The results of immunostaining for the rest of the 
markers are summarized in  table 3 .
 Molecular Biological Findings 
 Monoclonal TCR-γ gene rearrangement was found in 
3 of the 5 cases studied. The remaining cases (cases 1 and 
4) revealed no clonal T cell population. In none of the four 
investigated specimens was EBER detected.
 Discussion 
 Occasional cases of PCALCL with angioinvasive infil-
trates or cytotoxic phenotype have been reported in the 
literature, but this lymphoma variant (combining both 
Table 2.  Angioinvasive PCALCL: histopathological features
Ulceration of the epidermis 4/6
Epidermal hyperplasia 1/6
Vacuolar alteration in the basal layer 1/6
Prominent edema in the papillary dermis 0/6
Predominantly perivascular infiltrate 3/6
Predominantly diffuse infiltrate 2/6
Infiltration and destruction of vessel walls 6/6
Thrombi in the infiltrated vessels 4/6
Erythrocyte extravasation 4/6
Conspicuous eosinophils 4/6
Conspicuous neutrophils 1/6
Subcutis involvement 3/6
Perineural or intraneural invasion 0/6
Adnexal involvement 4/6
b
c d
 Fig. 2. A dense non-epidermotropic infiltrate with angiocentric growth and involvement of several vessels in the 
dermis and subcutis and areas of dermal necrosis ( a ). Close-up view of pleomorphic cells infiltrating the vessel 
wall ( b ) co-expressing CD30 ( c ) and CD8 ( d ). 
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features) has rarely been studied systematically  [18, 19] . 
Plaza et al.  [20] have recently reported 9 cases of CD30+ 
ALCL involving the skin with expression of CD8, includ-
ing a single case of systemic ALCL secondarily involving 
the skin. None of the cases showed angiocentric/angiode-
structive features. The only vascular involvement was 
represented by a striking intravascular localization of 
neoplastic cells seen in one case accompanied by signi f-
icant extravascular infiltration by neoplastic cells. Par-
enthetically, apart from ALCL, the authors studied 12 
cases of CD30+CD8+ LyP and noted angiocentricity of 
the infiltrate in half of them. Angiocentricity in LyP with 
or without cytotoxic phenotype has occasionally been re-
ported  [21–26] . In a large series of PCALCL, Massone et 
al.  [18] identified angiodestruction in 10 of 66 specimens 
(15%) from 47 patients. Although no immunophenotype 
was provided, the authors commented that in their expe-
rience and that of others, cases of ALCL with angiode-
struction often show cytotoxic phenotype. In the paper of 
Kummer et al.  [27] , who specifically studied the expres-
sion of cytotoxic molecules in cutaneous CD30+ LPD, no 
vascular abnormalities (angiocentric infiltrates) were 
however mentioned. In our series, expression of a cyto-
toxic phenotype was found in 4 out of the 6 cases.
 In the present series, we investigated 6 cases of this en-
tity which greatly resembles histopathologically angioin-
vasive LyP type E  [12] . In fact, on the histopathological 
grounds alone these two conditions cannot be distin-
guished. Decisive is the clinical information (including 
history of the disease), but given that in some cases of an-
gioinvasive LyP there may be a solitary lesion at initial 
presentation (or at a given time point), the discrimination 
between this ALCL variant and LyP type E can sometimes 
be achieved only during the follow-up of the patients. All 
our cases of LyP type E demonstrated in the course of the 
disease the typical course with occurrence of new lesions 
and regression of other lesions. Usually, the lesions in LyP 
type E persisted for 3–6 weeks before undergoing sponta-
neous regression. The first relapse usually occurred with-
in 1 year, but in one case it took as long as 4 years after 
initial presentation, emphasizing the fact that in such rare 
cases one needs a long follow-up to classify the case as 
PCALCL or angioinvasive LyP  [12] . Moreover, it cannot 
be entirely excluded that angiocentric PCALCL may pre-
cede angiocentric LyP in those patients.
 This further reiterates the concept that LyP and
PCALCL comprise a clinicopathological spectrum. A ste-
reotypical example of LyP is characterized by multiple 
small (<2 cm) self-regressing lesions, with the typical 
waxing and waning course, whereas the classic presenta-
tion of PCALCL is that of a solitary large (usually >2 cm) 
lesion persisting longer (at least 3–4 weeks). In some cas-
es of CD30+ LPD, patients present with few lesions and/
or nodules measuring near 2 cm and such cases showing 
features of PCALCL are sometimes referred to as border-
line  [28] . A further demonstration of the clinicopatho-
logical continuum are rare cases where ALCL is followed 
by LyP or concomitant occurrence of large solitary le-
sions as typical for PCALCL and of small recurrent le-
sions as typical for LyP in the same patient  [29] . In this 
respect, case 5 in the current series may also be regarded 
as a borderline case, as the patient first presented with a 
solitary 4 × 5 cm lesion, but experienced local recurrence 
with smaller nodules.
 Given the angiodestructive pattern of the infiltrate, the 
differential diagnosis of this PCALCL variant, apart from 
LyP type E, also includes extranodal T/NK cell lympho-
ma, nasal type, cutaneous γ/δ-positive T cell lymphoma, 
adult T cell leukemia/lymphoma and EBV-associated hy-
droa vacciniforme-like lymphoma. The distinction from 
these aggressive lymphomas can in most cases be easily 
achieved by immunhistochemistry, as discussed else-
Table 3.  Angioinvasive PCALCL: immunohistochemical features
Case CD2 CD3 CD4 CD5 CD7 CD8 CD30 ALK CD56 TIA Gran TCR-γ βF1 EBER
1 + +/– + + –/+ + + – – – ND – + ND
2 + –/+ + + – + + ND – + ND ND ND –
3 + + +/– + –/+ + + – – +/– ND – ND –
4 + + +/– + +/– + + – – + + – + –
5 + + + + –/+ +/– + – – – ND – + ND
6 + + –/+ + +/– + + – – –/+ ND ND + –
 Gran = Granzyme B; ND = not done.
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where  [12] . Systemic CD30+ ALCL involving the skin is 
also a differential diagnostic consideration, as rare cases 
may manifest angiocentric/angiodestructive pattern in 
the skin  [30] . Occasional cases of pityriasis lichenoides 
et varioliformis acuta (PLEVA) that show exuberant 
CD30+CD8+ lymphocytes and signs of vasculitis are eas-
ily distinguished from this ALCL variant clinically (mul-
tiple small erythematous macules quickly evolving in-
to necrotic papules) and, besides, CD30+CD8+ cells in 
PLEVA are small lymphocytes showing no involvement 
of deeply located blood vessels  [31] . Lastly, exceptional 
cases of cutaneous aggressive epidermotropic cytotoxic 
CD8+ T cell lymphoma can display an angiocentric pat-
tern but lack expression of CD30 and show prominent 
epidermotropism of small lymphocytes  [32] .
 In conclusion, we present a rare variant of ALCL char-
acterized by an angiocentric/angiodestructive pattern 
and cytotoxic phenotype. The significance of recognition 
of this type lies in its obligate separation from aggressive 
lymphomas typified by an angioinvasive pattern, includ-
ing nodal ALCL secondarily involving the skin. It shows 
phenotypic and histopathological overlap with LyP type 
E on the other hand, which further corroborates the con-
cept of a clinicopathological spectrum of CD30+ LPD of 
the skin.
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